Insider Trading activities at Neurobiological Technologies Inc /ca/ (NTII)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neurobiological Technologies Inc /ca/ (NTII) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neurobiological Technologies Inc /ca/. Table 2 shows the detailed insider transactions. This company's CIK number is 918112.

Total stock buying since 2010: $33,729.
Total stock sales since 2010: $0.
Total stock option exercises since 2010: $0.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


1 insider reported insider trading activities at Neurobiological Technologies Inc /ca/ (NTII):
Insider trading activities of Heslop Ryan

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Neurobiological Technologies Inc /ca/ (NTII).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2010 449,733 $33,729 0 $0 0 $0

Table 2. Monthly summary of insider trading at Neurobiological Technologies Inc /ca/ (NTII).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-06 20,533 $1,539 0 $0 0 $0
2010-05 429,200 $32,190 0 $0 0 $0

Table 3. Detailed insider trading at Neurobiological Technologies Inc /ca/ (NTII)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-06-07 Heslop Ryan (10% Owner) Buy 20,533 .07 1,539
2010-05-21 Heslop Ryan (10% Owner) Buy 100,000 .07 7,500
2010-05-20 Heslop Ryan (10% Owner) Buy 30,000 .07 2,250
2010-05-19 Heslop Ryan (10% Owner) Buy 44,200 .07 3,315
2010-05-11 Heslop Ryan (10% Owner) Buy 255,000 .07 19,125

Insider trading activities including stock purchases, stock sales, and option exercises of NTII listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neurobiological Technologies Inc /ca/ (symbol NTII, CIK number 918112) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.